Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. NASDAQ OMX GlobeNewswire Message Board

Visiongain’s publishes new report on the Global

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 301275
(Total Views: 105)
Posted On: 10/16/2017 8:00:20 AM
Avatar
Posted By: News Desk 2018
Visiongain’s publishes new report on the Global Angioplasty Balloons Market 2017-2027

LONDON, Oct. 16, 2017 (GLOBE NEWSWIRE) -- Angioplasty Balloons – our new study reveals trends, R&D progress, and predicted revenues.

Where is the Angioplasty Balloons market heading? If you are involved in this sector you must read this brand new report. Visiongain’s report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.

For free report sample pages click on: https://www.visiongain.com/Report/1847/Global...-2017-2027

Discover How to Stay Ahead Our 131-page report provides 94 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing market. See how to exploit the opportunities with this report, now.

For a free report overview please email sara.peerun@visiongain.com or call her on +44 20 7549 9987

Forecasts to 2027 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets Along with revenue prediction for the overall world market, there are forecasts for 4 Product Types and 2 Applications.

Angioplasty Balloons Market Forecasts to 2027, By Product Type

  • Normal Balloons
  • Drug-Eluting Balloons
  • Cutting Balloons
  • Scoring Balloons

Angioplasty Balloons Market Forecasts to 2027, By Application

  • Coronary Artery Disease
  • Peripheral Artery Diseases

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 12 leading national markets:

  • The US
  • Germany
  • France
  • The UK
  • Italy
  • Spain
  • Japan
  • China
  • India
  • Brazil
  • Russia
  • Mexico
  • RoW

The report also includes profiles and forecasts for some of the leading companies in the Angioplasty Balloon market, with a focus on the Vascular segment of these companies’ operations.

There will be growth in both established and in developing countries. Our analyses show that the developing markets, China and India in particular, will continue to achieve high revenue growth to 2027. Developments worldwide in medical device regulation, especially in the US and Japan will influence the market.

Leading companies and the potential for market growth Overall world revenue for Angioplasty Balloons will surpass $2.6bn in 2017, our work calculates. We predict strong revenue growth through to 2027. Increasing incidence of cardiovascular and peripheral arterial diseases, rising healthcare expenditure in emerging countries and the increasing geriatric population are likely to drive the market over the forecast period.

Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Angioplasty Balloon Market report helps you In summary, our 131-page report provides you with the following knowledge:

  • Revenue forecasts to 2027 for the world Angioplasty Balloon market and 2 different segmentations, with 4 product types and 2 applications – discover the industry’s prospects, finding the most lucrative places for investments and revenues
  • Revenue forecasts to 2027 for 12 of the leading national markets – US, Germany, UK, France, Italy, Spain, Japan, Brazil, China, India, Russia, Mexico and the Rest of the World.
  • Discussion of what stimulates and restrains companies and the market
  • Prospects for established firms and those seeking to enter the market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain’s study is for everybody needing commercial analyses for the Angioplasty Balloon market and leading companies. You find data, trends and predictions.

Companies Listed in this report include:

Abbott Laboratories Abbott Vascular Advanced Stent Technologies, Inc. Alvimedica Angiodynamics AngioScore, Inc. Arthesys Aspire Pharmaceuticals Baxter International Inc Becton Dickinson & Co Biometrix Biosensors International Biotronik AG Boston Scientific Corporation BrosMed Medical C. R. Bard, Inc Cardinal Health Comed Cook Medical Cordis Covidien plc Demax Medical Demax Medical Technology Dispomedica ENDOCOR GmbH Endo-Flex Ethicon EuRoCor Guidant Boston Scientific Hexacath Integra LifeSciences JW Medical Lepu Medical Lutonix, Inc Maquet Medico Medicon, Inc Medi-Globe Medtronic plc Meril Life Sciences Pvt. Ltd MicroPort MicroPort Minvasys Natec Medical Neich Medical Olympus Corporation Optimed OrbusNeich Oscor QT Vascular ReCor Medcial Sahajanand Medical Technologies Pvt Ltd Scimed, Inc. Sequent Medical Sino Medical Smith & Nephew Smiths group Spectranetics Corporation Spectranetics Deutschland GmbH St. Jude Medical Tendyne Holdings, Inc. Terumo Corporation Terumo Heart, Inc. Terumo Medical Corporation TriReme Medical Vance Products, Inc. Vascular Pathways, Inc W. L. Gore & Associates, Inc. Yinyi, Synexmed YMed, Inc.



(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us